Yunu Launches De-ID & Export to Simplify Site-to-Sponsor Trial Data Sharing
New Capabilities Help Sites Anonymize and Export Trial Images and Results With Greater Control, Stronger Traceability, and Less Manual Effort ...
Veterans
CVS Health Reinforces Longstanding Support for the Military Community
Delivering care, connection, and opportunity to military‑connected families nationwide Originally published on CVS Health Company Newsroom WOONSOCKET, RI / ACCESS Newswire...
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury
U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans...
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA; OTCQB: MDXXF) (“PharmAla” or the “Company”), a...
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
- Surgical Implant – Next Generation contract makes Symvess more easily accessible to 170 VA hospitals – - SAC awards...
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
Transaction Positions JUNS at the Forefront of Next-Generation MDMA-Based Therapeutics Following President Trump's April 18, 2026, Executive Order Accelerating Psychedelic...
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian...
Organon to Present New Research on Access and Value at ISPOR 2026
New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women’s health and general medicines portfolioJERSEY CITY,...
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
New Haven-based biotech venture creation platform focused on launching early-stage therapeutics companies from breakthrough Yale University researchNEW HAVEN, Conn., May...
Military Compression, a Division of 1 Natural Way, Rebrands to Go Strong Supply, Launches New Medical-Grade Custom Boot Orthotics
Rebrand reflects expanded commitment to military, with expansion from compression wear into custom orthotics for active-duty service members. MAUMEE, OH...
Beckett’s Closes US$500,000 5-Year 8% Convertible Debenture Financing
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - May 11, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company")...
Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm
TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2...
Tria Federal Unveils Integrated Solutions Platform and New Website
Tria helps federal health agencies achieve their critical missions by navigating complex tradeoffs between cost, quality, and access to care...
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo...
AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization...
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
Vancouver, Canada, May 05, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech...
Avicanna Announces Change in Board of Directors
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a...
Beckett’s Secures US$500,000 in Convertible Debenture Financing and Files 2025 Fiscal Year-End Results
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - May 1, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company")...
Delta Dental renews partnership with Disabled American Veterans, commits $150,000 in support of its mission
ERLANGER, Ky., April 28, 2026 /PRNewswire/ -- DAV (Disabled American Veterans) announced today that it has renewed its partnership with...
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark...